Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.

Christopher DawoudKerstin Melanie WidmannSascha CzipinMichael PramhasMartina ScharitzerAnton StiftFelix HarpainStefan Riss

Published in: Wiener klinische Wochenschrift (2023)

Darvadstrocel is a safe, minimally invasive surgical technique without significant perioperative complications. Clinical success can be expected in about half of the treated patients.

Keyphrases

minimally invasive
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
cross sectional
patients undergoing
clinical trial
acute kidney injury
double blind